Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Choosing Wisely: Evaluating Latent Factor Models in the Presence of a Contaminated Instrumental Variable with Varying Strength 0 1 1 2 2 3 15 39
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 0 48 1 3 48 142
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 0 0 1 15 2 2 15 39
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 0 0 0 5 2 3 20 35
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 1 48 2 3 25 203
Estimating Lifetime or Episode-of-illness Costs 0 0 2 110 4 4 14 301
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 1 2 7 162
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 1 1 19 6 7 23 123
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 39 1 2 13 205
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 1 2 292 2 3 17 889
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 1 47 2 2 14 175
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 0 16 2 2 10 32
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 0 86 1 4 27 185
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 3 3 11 48
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 1 63 3 4 20 119
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 1 51 0 3 15 50
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 3 5 34 85
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 0 1 12 241
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 4 8 17 123
The Role of Physician Altruism in the Physician-Industry Relationship 0 0 2 13 1 1 17 33
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 0 3 10 111
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 4 4 11 175
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 2 2 15 65
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 54 1 2 12 231
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 0 2 486 4 4 18 1,364
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 0 147 2 4 13 538
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 4 5 14 70
Total Working Papers 0 3 15 1,887 59 89 467 5,783


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 0 0 5 30
Comparing alternative models: log vs Cox proportional hazard? 0 3 4 152 1 5 15 587
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 3 3 12 330
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 0 2 8 54
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 1 1 11 260
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 3 3 8 56
Estimating lifetime or episode‐of‐illness costs under censoring 0 0 2 23 3 3 22 106
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 0 145 5 5 11 432
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 0 143 3 3 15 374
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 1 1 9 34
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 0 0 105 4 4 19 308
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 4 5 19 209
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 0 1 15
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 1 40 2 3 9 162
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 1 1 9 111
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 2 3 10 57
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 2 2 19 37
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 0 1 53 0 1 8 225
The impact of comparative effectiveness research on health and health care spending 0 0 0 35 0 2 16 292
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 1 5 19 947 7 18 100 2,831
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 4 5 13 49
Total Journal Articles 1 8 27 1,796 46 70 339 6,559


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 0 28 1 3 18 262
Total Software Items 0 0 0 28 1 3 18 262


Statistics updated 2026-11-12